A Rutgers Global Health Institute initiative combines advancements in telemedicine with lessons learned from earlier battles against HIV to increase cancer survival rates in an area that needs it the most.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
The integration of cancer control into HIV settings in sub-Saharan Africa was the subject of Rutgers Global Health Institute director Richard Marlink’s presentation at the 23rd International AIDS Conference.
COVID-19 has reached many sub-Saharan African countries that are already suffering from malnutrition and disease, under-resourced health systems, and limited economic funding. Richard Marlink, director of Rutgers Global Health Institute and a leader in the global response to HIV/AIDS, discusses how this pandemic is likely to impact the African region and what can be done to help these countries.
In an op-ed for the Star-Ledger, Richard Marlink discusses the need to address cancer care and prevention disparities in sub-Saharan Africa, where aging HIV-positive populations face an increased risk of certain cancers.
During a seminar with the Rutgers cohort of 25 young African leaders, institute director Richard Marlink led a discussion about mobilizing three essential strategies to end the epidemic: follow the science, treat the whole person, and expand the health care workforce.
Programs to prevent HIV in transgender women are helping to lower the rate of new infection, but better care and treatment of this vulnerable population are still needed, especially among those with lower income or people of color, according to a study led by core faculty member Henry Raymond, an associate professor at the School of Public Health.
Healio.com’s Infectious Disease News spoke with institute director Richard Marlink, MD, who treated some of the first HIV/AIDS patients at St. Vincent’s Hospital in New York and helped establish the first HIV/AIDS clinic in Boston. In this interview marking the 30th anniversary of World AIDS Day, Marlink discusses the likelihood of a cure and vaccine, federal funding, testing among high-risk populations, PrEP, stigma, and medical treatment.
Thomas Sokolowski, director of Rutgers’ Zimmerli Art Museum, reflects on his work during the 1980s as a pioneer in activism through art. Challenging the world to fight the deadly epidemic that was just becoming known as AIDS, he and a small group of friends founded Visual AIDS, organized the first Day Without Art, and made the red ribbon an icon of awareness.
Assistant professor Umer Hassan, who grew up in Pakistan, remembers being fascinated by the handheld tricorder used to diagnose medical conditions on Star Trek. Now, he is working to recreate some of that technology in real life. As an engineer and a global health researcher, Hassan is developing biosensors that can quickly and inexpensively detect infections in people living with HIV/AIDS in underdeveloped countries.